KAAACI Guidelines for Allergen Immunotherapy.
Allergy Asthma Immunol Res
; 15(6): 725-756, 2023 Nov.
Article
en En
| MEDLINE
| ID: mdl-37957792
ABSTRACT
Allergen immunotherapy (AIT) is a causative treatment for various allergic diseases such as allergic rhinitis, allergic asthma, and bee venom allergy that induces tolerance to offending allergens. The need for uniform practice guidelines in AIT is continuously growing because of the increasing discovery of potential candidates for AIT and evolving interest in new therapeutic approaches. This guideline is an updated version of the Korean Academy of Asthma Allergy and Clinical Immunology recommendations for AIT published in 2010. This updated guideline proposes an expert opinion by allergy, pediatrics, and otorhinolaryngology specialists with an extensive literature review. The guideline deals with basic knowledge and methodological aspects of AIT, including mechanisms, clinical efficacy, patient selection, allergens extract selection, schedule and doses, management of adverse reactions, efficacy measurements, and special consideration in pediatrics. The guidelines for sublingual immunotherapy will be covered in detail in a separate article.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Allergy Asthma Immunol Res
Año:
2023
Tipo del documento:
Article